The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
My take on this is that we are looking at circa 5-6 months minimum before there is the potential for something to move the needle here.
Asset sales, whether property or rig will give transient single digit % upticks.
Similarly, we know rock chip samples, even great ones, don't create new base levels in the sp.
Bottom drawer for these & hoping assets are sold before the need to raise - dilution here would be bad news.
The FT reported this week:
Russia is to adopt powers to seize assets of "naughty" western companies and will make it harder for them to exit the country, as Vladimir Putin seeks ways to retaliate against US and European sanctions. The Kremlin last week secretly ordered legislation to enable western assets to be appropriated at knockdown prices and is discussing even more draconian measures to fully nationalize groups, according to people familiar with the deliberations.
Sorry TS, have to call you on the board buys as a sign of weakness - that's done pretty thin gruel.
I don't know what the% is, but in my experience director buys are met with a positive response.
ECR don't need excusing - they need to deliver.
"Cizzle continues to make excellent progress in developing its laboratory test for CIZ1B. Through refining our test we are now at a stage when we can commence work on our point of care test for use in doctors' offices and healthcare outlets such as pharmacies. "
- if they are now working on a point of care test, this suggests they have made some fairly significant progress, i would expect an rns confirming this shortly?
Poc test would only come once they are sure the lab based test does what is supposed to repeatably.